<DOC>
	<DOCNO>NCT00672412</DOCNO>
	<brief_summary>In 2005 , 50,620 HIV-infected child live Thailand . Current anti-HIV regimen , comprise individual pill drug , frequently lead missed dos . To properly control infection , regimens tolerable effective child without pill burden necessary . The primary purpose study evaluate safety bioavailability GPO-VIR Z30 , combination fix dose tablet contain zidovudine ( ZDV ) , lamivudine ( 3TC ) , nevirapine ( NVP ) , HIV-infected child Thailand .</brief_summary>
	<brief_title>Safety Pharmacokinetic Study Fixed Dose Combination Zidovudine , Lamivudine , Nevirapine HIV-Infected Children Thailand</brief_title>
	<detailed_description>An important factor affect therapeutic response ARVs adherence . A common reason poor adherence high pill burden . A combination fix dose drug approach appear effective strategy improve adherence therapeutic response . In study , investigator compare bioavailability safety GPO-VIR Z30 , combination fix dose drug , liquid formulation ZDV,3TC , NVP , child . This study last approximately 8 week . Participants randomly assign one two arm . Participants Arm 1 receive GPO-VIR Z30 2 week receive liquid formulation ZDV , 3TC , NVP follow 2 week . Participants Arm 2 receive liquid formulation ZDV , 3TC , NVP 2 week receive GPO-VIR Z30 follow 2 week . This study consist 4 study visit screen . Visits occur study entry Days 14 , 28 , 56 . Medical history physical exam occur visit . A pregnancy test occur females visit . Pharmacokinetic test , involve hospitalization 12 hour procedure , occur Days 14 28 . Safety adherence monitoring occur telephone Days 7 , 11 12 , 13 , 21 , 25 26 , 27 , 35 . Home visit directly observe therapy ( DOT ) may also occur .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Nevirapine</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<mesh_term>Lamivudine</mesh_term>
	<criteria>Weigh 6 30 kilogram HIV infect Receiving HAART regimen NVP 2 NRTIs . More information criterion find protocol . Agree use two appropriate form contraception . More information criterion find protocol . Ability swallow study drug Willing hospitalize 12hour intensive PK study Agree use two appropriate form contraception . More information criterion find protocol . Parent legal guardian able willing provide write informed consent Certain abnormal laboratory value . More information criterion find protocol . Vomiting diarrhea ( great Grade 2 ) within 30 day prior study entry History immunologic failure . More information criterion find protocol . Current treatment acute serious bacterial , viral , opportunistic infection History doselimiting toxicity require treatment discontinuation study drug Hypersensitivity study drug Surgical medical problem affect gastrointestinal motility absorption liver function Treatment experimental drug within 30 day prior study entry Acute hepatitis Chemotherapy active malignancy Any clinically significant disease finding screen medical history physical examination , opinion investigator , may interfere study Pregnant</criteria>
	<gender>All</gender>
	<minimum_age>5 Months</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Treatment Experienced</keyword>
</DOC>